ArticleFrontiers in endocrinology2026
Living with congenital adrenal hyperplasia: insights on quality of life.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Understanding the quality of life (QoL) and factors associated with improved outcomes in individuals with classical congenital adrenal hyperplasia (CAH) can meaningfully inform clinical care. Methods: Adults and caregivers of children with classical CAH completed a cross-sectional mixed-methods survey distributed via the CARES (Congenital Adrenal Hyperplasia Research Education and Support) Foundation website. QoL was assessed using a CAH-specific QoL instrument adapted from the CAHQL. Domains included general health (GH), adrenal insufficiency (AI), glucocorticoid excess (GE), physical functioning (PF), mental health and cognition (MHC); adult surveys also included social functioning (SoF) and sexual functioning (SeF). Scores were transformed to a 0-100 scale, with higher scores indicating better QoL. Results: A total of 362 surveys were analyzed (response rate 15.7%), including 151 (41%) completed by adults, and 211 (59%) completed by caregivers of children. Among adult respondents, 71.8% were female, 76% resided in the United States (US), 58.1% had private insurance and 18.7% received care from CARES Comprehensive Care Center (CCC)-affiliated providers. Among children, 50% were female, 73% lived in the US, 66% had private insurance and 22.3% received CARES CCC-affiliated care. Adults demonstrated mid-range mean QoL scores across domains with a total mean score of 58.1 (SD 17.7). Children had significantly higher median scores across all five domains (p<0.001, p<0.001, p<0.001, p=0.009, p<0.001). In adults, older age was associated with worse PF and SeF (both p<0.01). Female sex was associated with worse GE and SeF scores (both p<0.01). Public insurance was associated with worse QoL across most domains except for GE and PF (p= 0.01, p= 0.05, p= 0.03, p= 0.02, p= 0.02). In children, older age was associated with worse QoL across domains except PF (p<0.001 for all domains). CARES CCC affiliation was associated with significantly better AI and PF scores (p=0.03, p=0.02) in adults. Finally, long-acting steroid use was associated with worse GE scores (p= 0.03). Conclusion: Adults with CAH experience poorer QoL compared to children. Older age, female sex and public insurance were associated with worse QoL, while CARES CCC affiliation and hydrocortisone use were associated with improved outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.